Print
Email
Isis Pharmaceuticals Inc. has a market cap of $704.1 million; its shares were traded at around $7.06 with and P/S ratio of 6.5.
This is the annual revenues and earnings per share of ISIS over the last 10 years. For detailed 10-year financial data and charts, go to 10-Year Financials of ISIS.
CEO Recent Trades:
- Chairman, President, CEO Stanley T Crooke sold 63,300 shares of ISIS stock on 12/20/2011 at the average price of 6.82. Stanley T Crooke owns at least 875,391 shares after this. The price of the stock has increased by 3.52% since.
This is the insider trade history vs. stock price of ISIS. For the complete insider trading history of ISIS, click here.
Directors and Officers Recent Trades:
- Senior Vice President C Frank Bennett sold 5,500 shares of ISIS stock on 12/20/2011 at the average price of 6.82. C Frank Bennett owns at least 305 shares after this. The price of the stock has increased by 3.52% since.
- Senior Vice President Richard S Geary sold 3,900 shares of ISIS stock on 12/20/2011 at the average price of 6.82. Richard S Geary owns at least 4,278 shares after this. The price of the stock has increased by 3.52% since.
- Director, COO B Lynne Parshall sold 23,500 shares of ISIS stock on 12/19/2011 at the average price of 6.82. B Lynne Parshall owns at least 1,985 shares after this. The price of the stock has increased by 3.52% since.
- Senior Vice President C Frank Bennett sold 10,000 shares of ISIS stock on 08/04/2011 at the average price of 7.62. C Frank Bennett owns at least 305 shares after this. The price of the stock has decreased by 7.35% since.
- Senior Vice President C Frank Bennett sold 1,000 shares of ISIS stock on 07/28/2011 at the average price of 8.6. C Frank Bennett owns at least 305 shares after this. The price of the stock has decreased by 17.91% since.
For the complete insider trading history of ISIS, click here.
Subscribe RSS
